Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal

Q Jia1, J M Hogle, T Hashikawa

  • 1Department of Microbiology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan.

Journal of Virology
|November 2, 2001
PubMed

Insights

The mouse neurovirulence of poliovirus type 1 (PV1) is determined by specific amino acid residues within its capsid proteins. Mutations in VP1, VP2, or VP3 can restore the wild-type phenotype, indicating the importance of the virion surface structure.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Background:

  • The SA virus, a mutant of poliovirus type 1 (PV1/Mahoney), exhibits mouse neurovirulence, unlike its parent strain.
  • A key mutation at nucleotide 928 in the VP4 capsid protein (VP4062) confers this neurovirulence, associated with a small-plaque phenotype.

Purpose of the Study:

  • To identify additional amino acid residues involved in determining the host range of poliovirus.
  • To understand the structural basis of PV1 mouse neurovirulence.

Main Methods:

  • Isolation and characterization of large-plaque (LP) variants from a neurovirulent PV1 mutant (Mah/I4062M).
  • Molecular genetic analysis using recombinants to map mutations.
  • Analysis of amino acid substitutions in capsid proteins VP1, VP2, and VP3.

Main Results:

  • 14 LP variants were isolated, all lacking mouse neurovirulence.
  • 11 variants had a back mutation at nt 928, restoring the PV1/Mahoney nucleotide.
  • Three variants (LP8, LP9, LP14) showed second-site mutations in VP3, VP1, and VP2, respectively, restoring the wild-type phenotype.

Conclusions:

  • Specific amino acid substitutions at positions 107 (VP1), 33 (VP2), or 231 (VP3) are sufficient to abolish PV1 mouse neurovirulence.
  • These residues contribute to the overall virion surface structure, which dictates PV neurovirulence.